Table 1.
Baseline clinical and pathological characteristics of patients with aggressive variants of papillary thyroid carcinoma (PTC).
| Characteristics | Number (%) or Median (IQR) |
|---|---|
| Gender, Female | 27 (75.0%) |
| Age (years) | 43.5 (34.8–51.0) |
| ≥55 years | 7 (19.4%) |
| Pathology | |
| TCV-PTC | 25 (69.4%) |
| CCV-PTC | 11 (30.6%) |
| Surgery | |
| Lobectomy | 2 (5.6%) |
| TT with CND | 16 (44.4%) |
| TT with MRND | 18 (50.0%) |
| Primary tumor size | 2.0 (1.2–2.8) |
| >2 cm | 17 (47.2%) |
| Extrathyroidal extension | |
| Microscopic | 10 (27.8%) |
| Gross | 19 (52.8%) |
| Multifocality (yes) | 17 (47.2%) |
| Cervical lymph node metastasis (yes) | 32 (88.9%) |
| N1a | 14 (43.8%) |
| N1b | 18 (56.2%) |
| Distant metastasis | 0 (0.0%) |
| AJCC TNM 8th stage | |
| Stage I | 31 (86.1%) |
| Stage II | 4 (11.1%) |
| Stage III | 1 (2.8%) |
| Stage IV | 0 (0.0%) |
Abbreviations: IQR, interquartile range; TCV, tall cell variant; PTC, papillary thyroid carcinoma; CCV, columnal cell variant; TT, total thyroidectomy; CND, central neck dissection; SND, selective neck dissection; MRND, modified radical neck dissection; AJCC, American Joint Committee on Cancer; TNM, tumor–node–metastasis.